Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03927515
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.71 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.71 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.71 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.79 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.79 | |
140 | N-PALMITOYLGLYCINE | A,B | 1JPZ | 0.71 | |
140 | N-PALMITOYLGLYCINE | A,B | 1ZOA | 0.71 | |
140 | N-PALMITOYLGLYCINE | A,B | 3CBD | 0.71 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.85 | |
AFJ | (2R,4S,5S)-N-butyl-4-hydroxy-2,7- dimethyl-5-{[N-(4-methylpentanoyl)- L-methionyl]amino}octanamide | A,B,C | 3DUY | 0.72 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 3HY7 | 0.77 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 2JIH | 0.77 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A | 1R55 | 0.77 | |
76V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | A | 2DCB | 0.75 | |
BCV | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- D-CYCLOPROPYLGLYCINE | A | 2IVJ | 0.71 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.85 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.76 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.74 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.84 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.79 | |
2NC | N-{(2S)-2-[(N-acetyl-L-threonyl- L-isoleucyl)amino]hexyl}-L-norleucyl- L-glutaminyl-L-argininamide | A,B | 3BVA | 0.8 | |
042 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.74 | |
75V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.74 | |
CIB | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1- (1-FORMYL-PENTYLCARBAMOYL)-3-METHYL- BUTYL]-AMIDE | H,I,J,K,L,M,N | 1J2Q | 0.75 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.77 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.71 | |
AMK | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.71 |